Literature DB >> 7830049

PC12 cells overexpressing tissue plasminogen activator regenerate neurites to a greater extent and migrate faster than control cells in complex extracellular matrix.

R N Pittman1, A J DiBenedetto.   

Abstract

PC12 cells were stably transfected with expression vectors containing rat tissue plasminogen activator (tPA) under control of either a cytomegalovirus or rous sarcoma virus promoter. Cell lines were characterized using protease assays, ELISAs, immunoblots, northern blots, and Southern blots. Control PC12 cells or cells containing vectors alone released about 1 pg tPA/cell/24 h, whereas cells stably transfected with a tPA cDNA released 2-5 pg tPA/cell/24 h. A strong correlation existed between the amount of tPA released and the ability of cells to degrade extracellular matrix. Experiments with protease inhibitors and antibodies against tPA and plasminogen indicated that degradation of matrix involved tPA-generated plasmin and that the amount of matrix degraded was dependent on the amount of tPA released. Cells expressing high levels of tPA migrated on a three-dimensional matrix about twice as fast as control cells and regenerated neurites within three-dimensional gels of Matrigel to a greater extent than control cells. Antibodies that inhibited tPA and plasminogen decreased migration and neurite regeneration, indicating that tPA was involved in both events, PC12 cells overexpressing tPA should provide a useful model system for investigating neural functions of tPA including its role in migration and regeneration.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7830049     DOI: 10.1046/j.1471-4159.1995.64020566.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  19 in total

1.  Real-time imaging of the dynamics of secretory granules in growth cones.

Authors:  J R Abney; C D Meliza; B Cutler; M Kingma; J E Lochner; B A Scalettar
Journal:  Biophys J       Date:  1999-11       Impact factor: 4.033

2.  Quantitative assessment of neuronal differentiation in three-dimensional collagen gels using enhanced green fluorescence protein expressing PC12 pheochromocytoma cells.

Authors:  Hadar Arien-Zakay; Shimon Lecht; Anat Perets; Blair Roszell; Peter I Lelkes; Philip Lazarovici
Journal:  J Mol Neurosci       Date:  2008-07-16       Impact factor: 3.444

3.  Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.

Authors:  R M Hill; P K Parmar; L C Coates; E Mezey; J F Pearson; N P Birch
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

4.  Expression of neuroserpin, an inhibitor of tissue plasminogen activator, in the developing and adult nervous system of the mouse.

Authors:  S R Krueger; G P Ghisu; P Cinelli; T P Gschwend; T Osterwalder; D P Wolfer; P Sonderegger
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

5.  The novel plasminogen receptor, plasminogen receptor(KT) (Plg-R(KT)), regulates catecholamine release.

Authors:  Hongdong Bai; Nagyung Baik; William B Kiosses; Stan Krajewski; Lindsey A Miles; Robert J Parmer
Journal:  J Biol Chem       Date:  2011-07-27       Impact factor: 5.157

6.  Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin.

Authors:  S Sheng; B Truong; D Fredrickson; R Wu; A B Pardee; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

Review 7.  Can the time window for administration of thrombolytics in stroke be increased?

Authors:  Geoffrey A Donnan; David W Howells; Romesh Markus; Danilo Toni; Stephen M Davis
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Real-time imaging of the axonal transport of granules containing a tissue plasminogen activator/green fluorescent protein hybrid.

Authors:  J E Lochner; M Kingma; S Kuhn; C D Meliza; B Cutler; B A Scalettar
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  Plasminogen enhances neuritogenesis on laminin-1.

Authors:  Ana Gutiérrez-Fernández; Neill A Gingles; Hongdong Bai; Francis J Castellino; Robert J Parmer; Lindsey A Miles
Journal:  J Neurosci       Date:  2009-10-07       Impact factor: 6.167

10.  The glycosylation of Bowes melanoma tissue plasminogen activator: lectin mapping, reaction with anti-L2/HNK-1 antibodies and the presence of sulphated/glucuronic acid containing glycans.

Authors:  A J Jaques; G Opdenakker; T W Rademacher; R A Dwek; S E Zamze
Journal:  Biochem J       Date:  1996-06-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.